You are here:
POSSIBLE APPROACHES FOR THE ESTABLISHMENT OF INTERLABORATORY COMPARABILITY IN THE DETERMINATION OF POLYCHLORINATED BIPHENYLS IN HUMAN SERUM
Citation:
Burse, V., M. Korver, D. Phillips, P. McClure, S. Caudill, D. Miller, R. Timperi, R. Kappes, D. Buckley, K. Gallagher, J. Nassif, R. Peisch, AND R. Brown. POSSIBLE APPROACHES FOR THE ESTABLISHMENT OF INTERLABORATORY COMPARABILITY IN THE DETERMINATION OF POLYCHLORINATED BIPHENYLS IN HUMAN SERUM. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/J-92/034 (NTIS PB92144062), 1991.
Description:
The Massachusetts Department of Public Health, with the assistance of the centers for Disease Control, conducted a study to determine the prevalence of elevated levels (>30ppb) of polychlorinated biphenyls (PCBs) in serum taken from residents of the greater New Bedford area in Massachusetts. e describe the criteria and procedures used to establish interlaboratory comparability for measurements of PCBs in human serum, the establishment and performance of the quality control system, and the comparability of results on human serum samples from the New Bedford study. spects of interlaboratory comparability addressed include establishment of common extraction and analytical methods, joint analyses of bovine serum pools (both in vitro-spiked pools and in vivo pools from a cow that was fed PCBs), establishment of quality control charts and rules for acceptability of analytical runs, and joint analyses of a subset (n=207) of the human serum samples from the New Bedford study. he 207 jointly analyzed samples had PCB levels that ranged from 1 to 214 ppb and had an interlaboratory correlation coefficient of 0.96.